Chromatin immunoprecipitation with sequencing (ChIP-seq) analysis confirmed direct binding of ASCL1 to the promoter region of PROX1, and to enhancer and promoter regions of FOXA2, in both SCLC cell lines (Fig. 5i, j). The gene discussed is PROX1; the disease is small cell lung carcinoma.